Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

23andMe Holding Co. - Common Stock (NQ:ME)

0.6063 -0.1637 (-21.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about 23andMe Holding Co. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
How to Tune Out Market Noise
Via The Motley Fool
Topics Bankruptcy World Trade
Exposures Financial Legal Tariff
These stocks have an unusual volume in today's session
Which stocks have an unusual volume on Friday? 
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Lifeline For 23andMe? Stock Jumps After Court Greenlights Bankruptcy Asset Sale, Retail Weighs Possible Rescue Deals
Stocktwits users spotted a media report about Richard Magides, the director of Singapore-based Zentree Investment and 23andMe's second-largest shareholder, expressing interest in backing a rescue... 
Via Stocktwits
Topics Bankruptcy
Exposures COVID-19 Financial Legal
Top movers in Thursday's session
Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
These stocks are the most active in today's session
Stay updated with the latest market activity on Thursday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight. 
Via Chartmill
Top stock movements in today's session.
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Cybersecurity Stocks To Outperform, It's The 'One Line Item That No Company In The World Is Cutting': Josh Brown
Cybersecurity is "the one line item that no company in the world is cutting," Brown said, noting how a data breach brought down 23andMe. 
Via Benzinga
Topics Data Breach
Exposures Information Security
23andMe's Bankruptcy Sparks Privacy Concerns Over Genetic Database Of 15 Million Customers
23andMe files for Chapter 11 bankruptcy, raising concerns about genetic data security as legal challenges emerge over a $30 million data breach settlement. 
Via Benzinga
Topics Bankruptcy Data Breach
Exposures Financial Information Security Legal
US Stocks Likely To Open Lower After 2-Day Advance: Clear And Measured Tariff Plan Could 'Trigger A Strong Relief Rally,' Says Expert
U.S. stock futures declined on Tuesday, after advancing for two consecutive sessions on Friday and Monday. 
Via Benzinga
Microalgo, Palantir, 23Andme, AMD, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
The S&P 500 and Nasdaq posted their best gains in months, with the S&P 500 climbing 1.76% to 5,767.57 and the Nasdaq rising 2.3% to 18,188.59. 
Via Benzinga
Topics Stocks
Exposures US Equities
What's going on in today's session
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
Via Chartmill
These stocks are moving in today's session
Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Traders are paying attention to the gapping stocks in Monday's session.
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill
Crude Oil Gains 1%; US Composite PMI Surges In March
Via Benzinga
Exposures Fossil Fuels
Discover the top movers in Monday's pre-market session.
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
Dow Jumps Over 300 Points; Chicago Fed National Activity Index Rises In February
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Is DNA Test Provider 23andMe Stock Tumbling Today?
Shares of 23andMe are falling in premarket trading after the company filed for Chapter 11 bankruptcy to initiate a court-supervised sale process aimed at maximizing business value. 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
US Stocks Likely To Open Higher As Trump May Soften Tariff Plans: Analysts Brush Off Bear Hug Fears
Stock futures rise on bullish sentiment as Trump administration plans targeted tariffs against trading partners. 
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Monday's pre-market session: top gainers and losers
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
Trump's Metal Tariffs Set Stage For US Steel ETF Gains
Tariffs on metal imports create opportunities in ETFs focused on U.S. steelmakers. Top picks are VanEck Steel, SPDR S&P Metals & Mining, and Global X U.S. Infrastructure Development ETF. 
Via Benzinga
Topics ETFs Government Stocks
Exposures Political US Equities
Deal Dispatch: Lovely Day To Sell Guinness? Plus, 23andMe To Rid Lineage Of Lemonaid
Here's the latest M&A news and auction block updates. Among the most watched items: a TikTok deal is still in flux. 
Via Benzinga
Want $500 of Reliable Dividend Income in 2025? Invest $5,040 in These 3 Ultra-High-Yield Stocks.
Via The Motley Fool
The Shake-Up at Intel
And cybersecurity consultant Dave Hatter helps us see what's really going on with all of our information. 
Via The Motley Fool
Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs
23andMe restructures, cutting 40% of its workforce and ending its therapeutic programs to save $35 million annually while exploring strategic alternatives. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.